#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16268	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2010	803.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	967	C	869	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3343	904.2	0	.	n	.	0	T695C	SNP	695	695	T	903	903	C	896	C	799	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3343	904.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1846	1846	G	1002	G	893	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3343	904.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2179	2179	C	974	C,T	860,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3343	904.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2253	2253	A	935	A	839	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30352	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3343	904.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2805	2805	C	977	C,T	876,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2272	folP	852	852	99.77	folP.l15.c4.ctg.1	1455	155.6	0	.	p	.	0	S68P	NONSYN	202	204	TCG	502	504	CCG	209;212;213	C,T;C,T;G	184,1;188,1;192	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2272	folP	852	852	99.77	folP.l15.c4.ctg.1	1455	155.6	0	.	p	.	0	A204V	NONSYN	610	612	GCA	910	912	GTA	208;209;208	G;T;A	187;183;181	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2272	folP	852	852	99.77	folP.l15.c4.ctg.1	1455	155.6	1	SNP	p	R228S	1	.	.	682	684	AGC	982	984	AGC	229;222;222	A;G;C	207;201;199	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5590	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3437	162.3	1	SNP	p	S91F	1	.	.	271	273	TTC	619	621	TTC	174;173;179	T;T;C	159;160;163	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5590	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3437	162.3	1	SNP	p	G95N	0	.	.	283	285	GGC	631	633	GGC	174;174;176	G;G;C	166;166;168	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5590	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3437	162.3	1	SNP	p	D95G	1	.	.	283	285	GGC	631	633	GGC	174;174;176	G;G;C	166;166;168	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1798	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1349	133.1	1	SNP	p	G45D	0	.	.	133	135	GGC	468	470	GGC	225;226;227	G;G;C	199;197;203	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	888	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1033	85.7	0	.	n	.	0	A197.	DEL	197	197	A	574	574	A	228	A	201	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2852	204.7	1	SNP	p	D86N	0	.	.	256	258	GAC	511	513	GAC	225;228;231	G;A;C	196;199;206	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2852	204.7	1	SNP	p	R87I	0	.	.	259	261	CGT	514	516	CGT	233;231;230	C;G;T	204;203;202	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2852	204.7	1	SNP	p	S87R	1	.	.	259	261	CGT	514	516	CGT	233;231;230	C;G;T	204;203;202	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2852	204.7	1	SNP	p	R87W	0	.	.	259	261	CGT	514	516	CGT	233;231;230	C;G;T	204;203;202	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5854	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2852	204.7	1	SNP	p	S88P	0	.	.	262	264	TCC	517	519	TCC	232;233;232	T;C;C	203;206;204	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4816	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2485	192.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1510	1512	GGC	218;217;215	G;G;C,G	191;188;184,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1126	1128	GCC	237;238;234	G;C;C	217;217;212	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1129	1131	ATG	234;232;231	A;T;G	211;209;205	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1141	1143	ACC	221;221;224	A;C;C	199;199;200	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1141	1143	ACC	221;221;224	A;C;C	199;199;200	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1642	1644	ACC	239;240;240	A,G;C;C	206,1;212;216	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1696	1698	GCG	243;244;247	G;C;G	219;221;221	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1696	1698	GCG	243;244;247	G;C;G	219;221;221	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1819	1821	GGT	214;215;213	G;G;T	192;191;190	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1828	1830	AGC	203;202;202	A,G;G;C	180,1;180;181	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4508	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2181	205.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1846	1848	CCG	162;164;163	C,G;C;G	125,4;129;126	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6432	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	2999	213.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1587	1589	CCG	223;226;229	C;C;G	184;197;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2564	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1578	161.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	418	418	C	198	C	179	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3326	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1502	219.9	1	SNP	p	G120K	1	.	.	358	360	AAG	639	641	AAG	246;251;253	A;A;G	214;218;211	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3326	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1502	219.9	1	SNP	p	A121N	1	.	.	361	363	AAC	642	644	AAC	252;248;247	A;A;C	221;218;217	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3326	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1502	219.9	1	SNP	p	N121D	0	.	.	361	363	AAC	642	644	AAC	252;248;247	A;A;C	221;218;217	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12374	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4827	255.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1312	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1128	116.1	1	SNP	p	V57M	1	.	.	169	171	ATG	642	644	ATG	286;289;287	A;T;G	259;261;259	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
